Clinical Trial Update: AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating the weight loss effect of NNC0487-0111 in adults with overweight/obesity and type 2 diabetes (recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Obesity
• Overweight

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Overweight | Phase 3 | Status: RECRUITING